This content was funded by LEO Pharma.
Chronic hand eczema (CHE) is common in the US and carries a significant humanistic impact. Drawing on the CHECK patient survey and RWEAL medical chart review, conducted before the recent availability of non-steroidal topical therapy in the US, this infographic captures the prevalence and burden of CHE, and the high unmet need these data revealed.
Read the full infographic to explore:
- Which groups does CHE most commonly affect?
- How significant is the symptom burden of itch, pain, and sleep disturbance?
- How heavily do patients rely on topical corticosteroids (TCS), despite known challenges?
- What do US-focused expert recommendations advise when response to TCS is inadequate?
